Emerging applications of metabolomics in drug discovery and precision medicine - PubMed
Review
doi: 10.1038/nrd.2016.32. Epub 2016 Mar 11.
Affiliations
- PMID: 26965202
- DOI: 10.1038/nrd.2016.32
Review
Emerging applications of metabolomics in drug discovery and precision medicine
David S Wishart. Nat Rev Drug Discov. 2016 Jul.
Abstract
Metabolomics is an emerging 'omics' science involving the comprehensive characterization of metabolites and metabolism in biological systems. Recent advances in metabolomics technologies are leading to a growing number of mainstream biomedical applications. In particular, metabolomics is increasingly being used to diagnose disease, understand disease mechanisms, identify novel drug targets, customize drug treatments and monitor therapeutic outcomes. This Review discusses some of the latest technological advances in metabolomics, focusing on the application of metabolomics towards uncovering the underlying causes of complex diseases (such as atherosclerosis, cancer and diabetes), the growing role of metabolomics in drug discovery and its potential effect on precision medicine.
Similar articles
-
Applications of metabolomics in drug discovery and development.
Wishart DS. Wishart DS. Drugs R D. 2008;9(5):307-22. doi: 10.2165/00126839-200809050-00002. Drugs R D. 2008. PMID: 18721000 Review.
-
Metabolomics: moving to the clinic.
Nordström A, Lewensohn R. Nordström A, et al. J Neuroimmune Pharmacol. 2010 Mar;5(1):4-17. doi: 10.1007/s11481-009-9156-4. Epub 2009 Apr 28. J Neuroimmune Pharmacol. 2010. PMID: 19399626 Review.
-
The complementary roles of imaging and 'omics' for future anti-atherosclerotic drug development.
Puri R, Nissen SE. Puri R, et al. Curr Pharm Des. 2013;19(33):5963-71. doi: 10.2174/13816128113199990365. Curr Pharm Des. 2013. PMID: 23438963 Review.
-
Metabolomics through the lens of precision cardiovascular medicine.
Lam SM, Wang Y, Li B, Du J, Shui G. Lam SM, et al. J Genet Genomics. 2017 Mar 20;44(3):127-138. doi: 10.1016/j.jgg.2017.02.004. Epub 2017 Mar 8. J Genet Genomics. 2017. PMID: 28325553 Review.
-
The emergence of metabolomics as a key discipline in the drug discovery process.
Fillet M, Frédérich M. Fillet M, et al. Drug Discov Today Technol. 2015 Jun;13:19-24. doi: 10.1016/j.ddtec.2015.01.006. Epub 2015 Feb 28. Drug Discov Today Technol. 2015. PMID: 26190679 Review.
Cited by
-
Leveraging the potential of 1.0-mm i.d. columns in UHPLC-HRMS-based untargeted metabolomics.
La Gioia D, Salviati E, Basilicata MG, Felici C, Botrugno OA, Tonon G, Sommella E, Campiglia P. La Gioia D, et al. Anal Bioanal Chem. 2024 Oct 24. doi: 10.1007/s00216-024-05588-z. Online ahead of print. Anal Bioanal Chem. 2024. PMID: 39443364
-
Miller-Atkins G, Acevedo-Moreno LA, Grove D, Dweik RA, Tonelli AR, Brown JM, Allende DS, Aucejo F, Rotroff DM. Miller-Atkins G, et al. Hepatol Commun. 2020 Apr 26;4(7):1041-1055. doi: 10.1002/hep4.1499. eCollection 2020 Jul. Hepatol Commun. 2020. PMID: 32626836 Free PMC article.
-
Deep learning of multimodal networks with topological regularization for drug repositioning.
Ohnuki Y, Akiyama M, Sakakibara Y. Ohnuki Y, et al. J Cheminform. 2024 Aug 23;16(1):103. doi: 10.1186/s13321-024-00897-y. J Cheminform. 2024. PMID: 39180095 Free PMC article.
-
Leimanis-Laurens M, Gil D, Kampfschulte A, Krohn C, Prentice E, Sanfilippo D, Prokop JW, Lydic TA, Rajasekaran S. Leimanis-Laurens M, et al. Children (Basel). 2021 Feb 18;8(2):151. doi: 10.3390/children8020151. Children (Basel). 2021. PMID: 33670443 Free PMC article.
-
Tristán AI, Jiménez-Luna C, Abreu AC, Arrabal-Campos FM, Salmerón ADM, Rodríguez FI, Maresca MÁR, García AB, Melguizo C, Prados J, Fernández I. Tristán AI, et al. Sci Rep. 2024 Oct 10;14(1):23713. doi: 10.1038/s41598-024-74641-9. Sci Rep. 2024. PMID: 39390047 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources